NCT01383720View on ClinicalTrials.gov

REpositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus™ Valve SystEm

NACompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

May 31, 2012

Study Completion Date

May 9, 2017

Conditions
Aortic Valve StenosisAortic Valve CalcificationAortic Valve Disease
Interventions
DEVICE

Lotus Valve System

The Lotus Valve System includes the Lotus Valve, a bovine tissue tri-leaflet bioprosthetic aortic valve, and the Lotus Delivery Catheter for guidance and placement.

Trial Locations (3)

3040

St. Vincent's Hospital, Melbourne

3168

Southern Health Monash Medical Centre, Melbourne

5000

Royal Adelaide Hospital, Adelaide

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY